TD
Translational Development Acquisition Corp.
TDACU · NASDAQ
$11.60 -8.66% (-$1.10)
1M -4.45%
Market Cap $285.7M
P/E Ratio 51.61x
Div. Yield -
ROE 3.28%
Piotroski F-Score Moderate
6/9Valuation
29 /100
Expensive P/B 1.91x
P/E 51.61x
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
36 /100
Average ROA 3.52%
Asset turnover 0.00x
ROE 3.28%
Debt
0 /100
High Current ratio 0.06x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
0 /100
Unstable Beta 0.25x
EPS volatility N/A
Profitable years N/A
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o TDACU
Online
Sector
Financial Services
Industry
Shell Companies
CEO
Michael Hoffman
Employees
2
Headquarters
New York City